Salud financiera de hoja de balance de XianheLtd

Salud financiera controles de criterios 2/6

XianheLtd tiene un patrimonio de accionistas total de CN¥7.9B y una deuda total de CN¥10.8B, lo que sitúa su ratio deuda-patrimonio en 136.2%. Sus activos y pasivos totales son CN¥22.4B y CN¥14.5B respectivamente. El BAIT de XianheLtd es de CN¥1.1B, por lo que su ratio de cobertura de intereses es de -116.1. Tiene efectivo e inversiones a corto plazo que ascienden a CN¥1.1B.

Información clave

136.2%

Ratio deuda-patrimonio

CN¥10.80b

Deuda

Ratio de cobertura de intereses	-116.1x
Efectivo	CN¥1.15b
Patrimonio	CN¥7.94b
Total pasivo	CN¥14.51b
Activos totales	CN¥22.45b

Actualizaciones recientes sobre salud financiera

We Think XianheLtd (SHSE:603733) Is Taking Some Risk With Its Debt

Sep 24

Recent updates

Investors Shouldn't Be Too Comfortable With XianheLtd's (SHSE:603733) Earnings

Nov 06

A Piece Of The Puzzle Missing From Xianhe Co.,Ltd.'s (SHSE:603733) 39% Share Price Climb

Oct 09

We Think XianheLtd (SHSE:603733) Is Taking Some Risk With Its Debt

Sep 24

Some Investors May Be Worried About XianheLtd's (SHSE:603733) Returns On Capital

Aug 01

Market Might Still Lack Some Conviction On Xianhe Co.,Ltd. (SHSE:603733) Even After 26% Share Price Boost

Mar 04

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo (CN¥8.2B) de 603733 superan a sus pasivos a corto plazo (CN¥5.2B).

Pasivo a largo plazo: Los activos a corto plazo (CN¥8.2B) de 603733 no cubren sus pasivos a largo plazo (CN¥9.3B).

Historial y análisis de deuda-patrimonio

Nivel de deuda: La relación deuda neta-capital de 603733 (121.7%) se considera alta.

Reducción de la deuda: El ratio deuda-patrimonio de 603733 ha crecido de 31.8% a 136.2% en los últimos 5 años.

Cobertura de la deuda: La deuda de 603733 no está bien cubierta por el flujo de caja operativo (11.4%).

Cobertura de intereses: 603733 gana más intereses de los que paga, por lo que la cobertura de pagos de intereses no es preocupante.

Salud financiera de hoja de balance de XianheLtd

Salud financiera controles de criterios 2/6

Información clave

Actualizaciones recientes sobre salud financiera

We Think XianheLtd (SHSE:603733) Is Taking Some Risk With Its Debt

Recent updates

Investors Shouldn't Be Too Comfortable With XianheLtd's (SHSE:603733) Earnings

Third quarter 2024 earnings released: EPS: CN¥0.38 (vs CN¥0.28 in 3Q 2023)

A Piece Of The Puzzle Missing From Xianhe Co.,Ltd.'s (SHSE:603733) 39% Share Price Climb

Xianhe Co.,Ltd. to Report Q3, 2024 Results on Oct 30, 2024

Investor sentiment improves as stock rises 17%

We Think XianheLtd (SHSE:603733) Is Taking Some Risk With Its Debt

Second quarter 2024 earnings released: EPS: CN¥0.40 (vs CN¥0.087 in 2Q 2023)

Some Investors May Be Worried About XianheLtd's (SHSE:603733) Returns On Capital

Sentiment Still Eluding Xianhe Co.,Ltd. (SHSE:603733)

Xianhe Co.,Ltd. to Report First Half, 2024 Results on Aug 15, 2024

XianheLtd (SHSE:603733) Is Increasing Its Dividend To CN¥0.35

Dividend increased to CN¥0.35

Why Xianhe Co.,Ltd. (SHSE:603733) Could Be Worth Watching

XianheLtd's (SHSE:603733) Earnings Are Weaker Than They Seem

Xianhe Co.,Ltd., Annual General Meeting, May 17, 2024

Xianhe Co.,Ltd., Annual General Meeting, May 17, 2024

Xianhe Co.,Ltd. to Report Q1, 2024 Results on Apr 30, 2024

XianheLtd (SHSE:603733) Will Want To Turn Around Its Return Trends

Market Might Still Lack Some Conviction On Xianhe Co.,Ltd. (SHSE:603733) Even After 26% Share Price Boost

Investor sentiment deteriorates as stock falls 17%

Xianhe Co.,Ltd. to Report Fiscal Year 2023 Results on Apr 03, 2024

Price target decreased by 17% to CN¥25.00

Third quarter 2023 earnings released: EPS: CN¥0.28 (vs CN¥0.30 in 3Q 2022)

Less than half of directors are independent

Second quarter 2023 earnings released: EPS: CN¥0.087 (vs CN¥0.29 in 2Q 2022)

Xianhe Co.,Ltd. to Report First Half, 2023 Results on Aug 30, 2023

Price target increased by 8.3% to CN¥32.50

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Insufficient new directors

Third quarter 2022 earnings released: EPS: CN¥0.30 (vs CN¥0.42 in 3Q 2021)

Consensus EPS estimates fall by 11%

Second quarter 2022 earnings released: EPS: CN¥0.29 (vs CN¥0.46 in 2Q 2021)

Consensus EPS estimates fall by 31%

First quarter 2022 earnings: EPS and revenues miss analyst expectations

Price target increased to CN¥56.00

Insufficient new directors

Third quarter 2021 earnings released: EPS CN¥0.42 (vs CN¥0.32 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.46 (vs CN¥0.29 in 2Q 2020)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS CN¥0.40 (vs CN¥0.17 in 1Q 2020)

Full year 2020 earnings released: EPS CN¥1.13 (vs CN¥0.72 in FY 2019)

Investor sentiment deteriorated over the past week

New 90-day high: CN¥27.82

Investor sentiment improved over the past week

New 90-day high: CN¥25.44

New 90-day high: CN¥23.72

Market bids up stock over the past week

Market bids up stock over the past week

New 90-day low: CN¥18.41

Third quarter earnings released

Xianhe Co.,Ltd. to Report Q3, 2020 Results on Oct 30, 2020

First half earnings released

New 90-day high - CN¥20.10

Xianhe Co.,Ltd. to Report First Half, 2020 Results on Aug 13, 2020

Análisis de la situación financiera

Historial y análisis de deuda-patrimonio

Hoja de balance

Descubre empresas con salud financiera